We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ALKS market cap is 4.12B. The company's latest EPS is USD 2.1293 and P/E is 11.60.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 276.22M | 252.36M | 304.67M | 287.6M | 617.4M |
| Operating Income | -34.46M | -252.14M | -20.58M | -47.49M | 239.19M |
| Net Income | -30.14M | -63.97M | -28.25M | -41.85M | 237.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.17B | 1.04B | 1.17B | 1.11B | 1.66B |
| Operating Income | -175.48M | -112.43M | -29.29M | -142.27M | 414.12M |
| Net Income | -196.62M | -110.86M | -48.17M | -158.27M | 355.76M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.96B | 1.94B | 1.96B | 1.92B | 2.19B |
| Total Liabilities | 875.09M | 899.05M | 920.23M | 917.15M | 906.75M |
| Total Equity | 1.08B | 1.04B | 1.04B | 1.01B | 1.28B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.81B | 1.95B | 2.02B | 1.96B | 2.14B |
| Total Liabilities | 719.96M | 882.75M | 911.9M | 920.23M | 933.54M |
| Total Equity | 1.09B | 1.07B | 1.11B | 1.04B | 1.2B |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 19.37M | 20M | 21.04M | -21.3M | 194.41M |
| Investing | -101.18M | -92.28M | -64.54M | 72.85M | 193.7M |
| Financing | -1.09M | -1.3M | -1.57M | -22.62M | -14.78M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 72.08M | 82.84M | 101.72M | 21.04M | 401.35M |
| Investing | -141.83M | -11.48M | -66.2M | -64.54M | 53.36M |
| Financing | 6.77M | -2.17M | 29.07M | -1.57M | -289.71M |
| Market Cap | 4.12B |
| Price to Earnings Ratio | 11.60 |
| Price to Sales Ratio | 2.48 |
| Price to Cash Ratio | 9.02 |
| Price to Book Ratio | 3.43 |
| Dividend Yield | - |
| Shares Outstanding | 167.08M |
| Average Volume (1 week) | 1.68M |
| Average Volume (1 Month) | 1.9M |
| 52 Week Change | -17.07% |
| 52 Week High | 33.71 |
| 52 Week Low | 22.01 |
| Spread (Intraday) | 2.31 (9.24%) |
| Company Name | Alkermes PLC |
| Address |
connaught house dublin D04 C5Y6 |
| Website | https://www.alkermes.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
